Korean J Hematol 2011; 46(4):
Published online December 31, 2011
https://doi.org/10.5045/kjh.2011.46.4.244
© The Korean Society of Hematology
1Department of Medical Science, School of Medicine, Chungnam National University, Daejeon, Korea.
2Department of Internal Medicine, School of Medicine, Chungnam National University, Daejeon, Korea.
3Department of Internal Medicine, Daejeon Saint Mary's Hospital, Daejeon, Korea.
Correspondence to : Correspondence to Deog-Yeon Jo, M.D., Ph.D. Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University Hospital, 33 Munhwa-ro, Jung-gu, Daejeon 301-721, Korea. Tel: +82-42-280-7162, Fax: +82-42-257-5753, deogyeon@cnu.ac.kr
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Antagonists of CXC chemokine receptor 4 (CXCR4), including AMD3100, induce peripheral mobilization of hematopoietic stem cells and have been approved for clinical use. We explored whether the CXCR4 antagonists affected the survival and proliferation of myeloid leukemia cells
The effects of CXCR4 antagonists AMD3100 and T140 on the survival and proliferation of myeloid leukemia cell lines (U937, HL-60, MO7e, KG1a, and K562) as well as CD34+ cells obtained from patients with AML and CML were analyzed by flow cytometry by using annexin V and a colorimetric cell proliferation assay.
AMD3100, but not T140, stimulated the proliferation of leukemia cells
The effects of CXCR4 antagonists on the proliferation of myeloid leukemia cells are not uniform. AMD3100, but not T140, exerts dual effects, initially enhancing and subsequently inhibiting the survival and proliferation of the cells
Keywords AMD3100, CXCR4, SDF-1, Myeloid leukemia, Cell proliferation, Apoptosis
Korean J Hematol 2011; 46(4): 244-252
Published online December 31, 2011 https://doi.org/10.5045/kjh.2011.46.4.244
Copyright © The Korean Society of Hematology.
Ha-Yon Kim1, Ji-Young Hwang1, Yoon-Suk Oh1, Seong-Woo Kim1, Hyo-Jin Lee2, Hwan-Jung Yun2, Samyong Kim2, Young-Jun Yang3, and Deog-Yeon Jo2*
1Department of Medical Science, School of Medicine, Chungnam National University, Daejeon, Korea.
2Department of Internal Medicine, School of Medicine, Chungnam National University, Daejeon, Korea.
3Department of Internal Medicine, Daejeon Saint Mary's Hospital, Daejeon, Korea.
Correspondence to:Correspondence to Deog-Yeon Jo, M.D., Ph.D. Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University Hospital, 33 Munhwa-ro, Jung-gu, Daejeon 301-721, Korea. Tel: +82-42-280-7162, Fax: +82-42-257-5753, deogyeon@cnu.ac.kr
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Antagonists of CXC chemokine receptor 4 (CXCR4), including AMD3100, induce peripheral mobilization of hematopoietic stem cells and have been approved for clinical use. We explored whether the CXCR4 antagonists affected the survival and proliferation of myeloid leukemia cells
The effects of CXCR4 antagonists AMD3100 and T140 on the survival and proliferation of myeloid leukemia cell lines (U937, HL-60, MO7e, KG1a, and K562) as well as CD34+ cells obtained from patients with AML and CML were analyzed by flow cytometry by using annexin V and a colorimetric cell proliferation assay.
AMD3100, but not T140, stimulated the proliferation of leukemia cells
The effects of CXCR4 antagonists on the proliferation of myeloid leukemia cells are not uniform. AMD3100, but not T140, exerts dual effects, initially enhancing and subsequently inhibiting the survival and proliferation of the cells
Keywords: AMD3100, CXCR4, SDF-1, Myeloid leukemia, Cell proliferation, Apoptosis
AMD3100 and T140 inhibit the SDF-1-induced chemotaxis of myeloid leukemia cells, and trigger the internalization of surface CXCR4.
AMD3100 stimulates the proliferation of myeloid leukemia cells. Cells were incubated in the presence of AMD3100
AMD3100 induces the phosphorylation of SDF-1-linked signaling molecules.
Survival of leukemia cells in an extended period of culture.
Myeloid leukemia cells express CXCR7 on the cell surface, which is internalized by AMD3100.
Knockdown of CXCR7, but not CXCR4, delays the proliferation enhancement induced by AMD3100. U937 cells were transfected with 25 nM CXCR4 siRNA or 5 nM CXCR7 siRNA and were further incubated in serum-free medium in the presence or absence of AMD3100 for up to 3 days.
Ha-Yon Kim, So-Yeon Lee, Deog-Young Kim, Ji-Young Moon, Yoon-Seok Choi, Ik-Chan Song, Hyo-Jin Lee, Hwan-Jung Yun, Samyong Kim, and Deog-Yeon Jo
Blood Res 2015; 50(4): 218-226Seong Woo Kim, Ha Yon Kim, Hyo Jin Lee, Hwan Jung Yun, Sam yong Kim, Deog Yeon Jo
Korean J Hematol 2008; 43(3): 127-137Deog Yeon Jo, Jin Hee Hwang, Seung Keun Kwak, Hyun Young Shin, Sung Eun kim, Hwan Jung Yun, Sam Yong Kim, Chu Myong Seong
Korean J Hematol 2001; 36(4): 324-334
AMD3100 and T140 inhibit the SDF-1-induced chemotaxis of myeloid leukemia cells, and trigger the internalization of surface CXCR4.
AMD3100 stimulates the proliferation of myeloid leukemia cells. Cells were incubated in the presence of AMD3100
AMD3100 induces the phosphorylation of SDF-1-linked signaling molecules.
Survival of leukemia cells in an extended period of culture.
Myeloid leukemia cells express CXCR7 on the cell surface, which is internalized by AMD3100.
Knockdown of CXCR7, but not CXCR4, delays the proliferation enhancement induced by AMD3100. U937 cells were transfected with 25 nM CXCR4 siRNA or 5 nM CXCR7 siRNA and were further incubated in serum-free medium in the presence or absence of AMD3100 for up to 3 days.